PHP39 Explaning Differences in EU5 Market Penetration Levels and Rates of Biosimilars- The Case of Epoetine, Granulocyte-Colony Stimulating Factor, and Growth Hormones

Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.581
https://www.valueinhealthjournal.com/article/S1098-3015(12)02294-2/fulltext
Section Title : Health Care Use & Policy Studies
Section Order : 96
First Page : A295
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02294-2&doi=10.1016/j.jval.2012.08.581
HEOR Topics :
Tags :
Regions :